Scapa Healthcare is expanding its medical-grade adhesive coating capabilities in two of its facilities: Windsor, Conn., and Gargrave, United Kingdom.

The expansion enhances the company's ability to custom design and produce polyurethane and polyvinyl chloride foams coated with silicone gels, water-based and solvent-based acrylic adhesives. The firm also will now have the additional cabability of lamination and adhesive coating of non-wovens, breathable films, unsupported adhesives and many other substrates. This expansion strengthens the company’s ability to offer solid vertical integration with other Scapa sites to provide better economies of scale to medical device manufacturers.

“Our team of experts and full range of turn-key capabilities enable Scapa Healthcare to rapidly take a product from concept to market faster than many of our partners can do internally,” said John Petreanu, president of Scapa Healthcare. “The increased medical-grade adhesive coating capability further strengthens our value proposition and enables us to offer innovative and customized turn-key solutions to customers worldwide.”
 
The expanded medical adhesive coating capacity further enhances Scapa Healthcare’s position in offering complete contract development and manufacturing capabilities, from coating to conversion to packaging and sterilisation of finished products. Furthermore, Scapa features design expertise in the creation of innovative medical-grade adhesive solutions for medical device manufacturers. This includes the company’s own Soft-Pro adhesive range that meets needs spanning from high tack to low trauma and short-term to long-term wear requirements. 
 
Scapa Healthcare’s facilities are ISO-certified and FDA registered with cleanrooms and environmentally controlled rooms for full-scale production of finished goods.